Data on predictors of gestational
exposure to poly- and perfluoroalkyl
substances (PFASs) in the United States are limited. To fill in this
gap, in a multiethnic cohort of Ohio pregnant women recruited in 2003–2006,
we measured perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA),
and six additional PFASs in maternal serum at ∼16 weeks gestation
(N = 182) and delivery (N = 78),
and in umbilical cord serum (N = 202). We used linear
regression to examine associations between maternal serum PFASs concentrations
and demographic, perinatal, and lifestyle factors. PFASs concentrations
in maternal sera and in their infants’ cord sera were highly
correlated (Spearman rank correlation coefficients = 0.73–0.95).
In 71 maternal-infant dyads, unadjusted geometric mean (GM) concentrations
(95% confidence interval) (in μg/L) in maternal serum at delivery
of PFOS [8.50 (7.01–9.58)] and PFOA [3.43 (3.01–3.90)]
were significantly lower than at 16 weeks gestation [11.57 (9.90–13.53],
4.91 (4.32–5.59), respectively], but higher than in infants’
cord serum [3.32 (2.84–3.89), 2.85 (2.51–3.24), respectively]
(P < 0.001). Women who were parous, with a history
of previous breastfeeding, black, or in the lowest income category
had significantly lower PFOS and PFOA GM concentrations than other
women. These data suggest transplacental transfer of PFASs during
pregnancy and nursing for the first time in a U.S. birth cohort.